PSDV - EyePoint Pharmaceuticals, Inc.

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 555.21M
Enterprise Value 343.7M
Trailing P/E N/A
Forward P/E 1-2.39
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)21.16
Price/Book (mrq)5.57
Enterprise Value/Revenue 316.75
Enterprise Value/EBITDA 6-2.00

Financial Highlights

Fiscal Year

Fiscal Year Ends Jun 30, 2017
Most Recent Quarter (mrq)Dec 31, 2017


Profit Margin 0.00%
Operating Margin (ttm)-870.72%

Management Effectiveness

Return on Assets (ttm)-83.66%
Return on Equity (ttm)-186.65%

Income Statement

Revenue (ttm)2.61M
Revenue Per Share (ttm)0.07
Quarterly Revenue Growth (yoy)-84.40%
Gross Profit (ttm)N/A
EBITDA -21.85M
Net Income Avi to Common (ttm)-23.02M
Diluted EPS (ttm)-0.59
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)12.88M
Total Cash Per Share (mrq)0.28
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)3.21
Book Value Per Share (mrq)0.22

Cash Flow Statement

Operating Cash Flow (ttm)-20M
Levered Free Cash Flow (ttm)-11.37M

Trading Information

Stock Price History

Beta -1.28
52-Week Change 3-39.55%
S&P500 52-Week Change 313.44%
52 Week High 32.45
52 Week Low 30.93
50-Day Moving Average 31.18
200-Day Moving Average 31.17

Share Statistics

Avg Vol (3 month) 3391.09k
Avg Vol (10 day) 31.18M
Shares Outstanding 545.26M
Float 43.19M
% Held by Insiders 14.62%
% Held by Institutions 120.92%
Shares Short 31.1M
Short Ratio 31.28
Short % of Float 32.44%
Shares Short (prior month) 31.13M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/4
Last Split Date 3Jun 11, 2008